Diabetes is a serious, chronic condition which effects metabolism. A person with diabetes cannot convert glucose into energy so they often have trouble performing even simple activities because of lack of energy. Sometimes this also affects concentration.
Because the condition involves the metabolism of sugar diabetics usually minimize their sugar and carbohydrate consumption as well as monitor their blood sugar levels and perhaps even take medications to help remain balanced. It is a condition which can be hereditary but you can also develop diabetes (type II) over time.
Approximately 25.8 million people in the United States suffer from this condition—and of that population about 215,000 are under the age of 20. If the condition goes on untreated it can result in hyperglycemia and lead to serious health conditions down the road, which can include: heart disease, stroke, circulation problems, and damage to the eyes, nerves, and kidneys.
Fortunately, the US Food and Drug Administration has just approved the first monitoring device that promises to make diabetes maintenance a little bit easier for all of the people who struggle with it every single day.
“This innovative technology has been eagerly awaited by the diabetes community, especially caregivers of children with diabetes who want to monitor their glucose levels remotely. Today’s marketing permission paves the way for similar technologies to be marketed in the United States” explains Alberto Gutierrez, PhD. He is the director of the Office of In Vitro Diagnostics and Radiological Health for the FDA’s Center for Devices and Radiological Health.
Gutierrez explains “Exempting devices from premarket review is part of the FDA’s effort to ensure these products provide accurate and reliable results while still encouraging the development of devices that meet the needs of people living with diabetes and their caregivers.”
